As Byetta Lawsuits Move Forward, Bernstein Liebhard LLP Notes New FDA...

The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic...(PRWeb February 13, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb11583185.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news